Investors in Akebia Therapeutics (NASDAQ:AKBA) Have Unfortunately Lost 73% Over the Last Five Years

Yahoo FinanceDec 20 20:27

Express News | Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 4 05:05

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PR NewswireDec 4 05:05

Express News | U.S. Renal Care Enrolled First Patients in the Voice Collaborative Clinical Trial of Vafseo® (Vadadustat) for Ckd Patients on Dialysis

BreakingsDec 3 20:00

U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo (Vadadustat) for CKD Patients on Dialysis

PR NewswireDec 3 20:00

Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference

PR NewswireNov 25 21:00